Lille, France

Antoine Rauch

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.6

ph-index = 1


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Antoine Rauch**

Introduction

Antoine Rauch is an innovative inventor based in Lille, France, known for his contributions to medical biotechnology. With a total of three patents to his name, his work primarily revolves around the development of monoclonal antibodies aimed at preventing and treating bleeding episodes in patients. His inventions are significant in the field of medical research and treatment.

Latest Patents

Antoine Rauch's latest patents focus on isolated monoclonal antibodies that specifically bind to the D4 domain of von Willebrand Factor (VWF). These antibodies compete for binding with ADAMTS13, partially inhibiting its degradation of VWF. More specifically, his patented antibodies contain a heavy chain with variable domains that feature specific complementary-determining regions (CDRs), as well as a light chain with its own set of CDRs. The antibodies are particularly useful for preventing or treating bleeding episodes in patients suffering from aortic stenosis or those with ventricular assist devices (VAD).

Career Highlights

Throughout his career, Antoine Rauch has made significant strides in the realm of biomedical research. He has been associated with reputable institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the University of Paris-Sud, contributing to advancements in medical technologies and therapeutic approaches.

Collaborations

Antoine has worked alongside notable professionals in his field, including Sophie Susen and Petrus Lenting, showcasing a collaborative approach to innovation and research. These partnerships have likely enriched his work, leading to impactful inventions.

Conclusion

Antoine Rauch stands out as a prominent inventor in the medical biotechnology sector, with his innovative patents paving the way for improved treatment options for patients experiencing bleeding episodes. His contributions underscore the importance of research and innovation in the medical field, highlighting the potential of monoclonal antibodies in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…